Azzad Asset Management Inc /Adv Ginkgo Bioworks Holdings, Inc. Transaction History

Azzad Asset Management Inc /Adv

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Apr 01, 2024	SELL	$1.14 - $1.95 $30,670 - $52,462	-26,904 Closed	0 $0
Q1 2023 Apr 01, 2024	BUY	$1.2 - $2.19 $5,029 - $9,178	4,191 Added 18.45%	26,904 $35.8 Million
Q4 2022 Apr 01, 2024	BUY	$1.63 - $3.52 $11,092 - $23,953	6,805 Added 42.78%	22,713 $38.4 Million
Q3 2022 Apr 01, 2024	SELL	$0.73 - $3.74 $489 - $2,509	-671 Reduced 4.05%	15,908 $49.6 Million
Q2 2022 Apr 01, 2024	BUY	$2.2 - $4.2 $36,473 - $69,631	16,579 New	16,579 $39.5 Million

345

925M

1.04M

2.23M

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $10.5B
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

Get notified when there are updates to the investment portfolio of Azzad Asset Management Inc /Adv, based on Form 13F filings with the SEC.

Stay updated on Azzad Asset Management Inc /Adv with notifications on news.